EMPI
BCRX icon

Elo Mutual Pension Insurance’s BioCryst Pharmaceuticals BCRX Stock Holding History

Elo Mutual Pension Insurance’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$960K Buy
95,962
+39,913
+71% +$361K 0.01% 512
2026
Q1 		$534K Sell
56,049
-67,490
-55% -$524K 0.01% 544
2025
Q4 		$964K Sell
123,539
-3,965
-3% -$28.7K 0.01% 512
2025
Q3 		$968K Buy
127,504
+48,467
+61% +$404K 0.02% 521
2025
Q2 		$708K Buy
+79,037
New +$736K 0.01% 520

Other funds holding BCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Elo Mutual Pension Insurance's BCRX Position: Q2 2026 in Review

Elo Mutual Pension Insurance increased its BioCryst Pharmaceuticals (BCRX) stake by 71% in Q2 2026, buying an estimated $361K and bringing the position to 95,962 shares worth $960K. The position accounts for 0.01% of the portfolio, ranked #512.

Elo Mutual Pension Insurance first reported a position in BCRX in Q2 2025 and has held it in 5 quarters since. The position peaked at $968K in Q3 2025. 318 funds tracked by Wall St. Rank hold BCRX as of Q2 2026.

  • Elo Mutual Pension Insurance held 95,962 shares of BioCryst Pharmaceuticals worth $960K as of Q2 2026.
  • Elo Mutual Pension Insurance bought 39,913 BioCryst Pharmaceuticals shares in Q2 2026, an estimated $361K.
  • BioCryst Pharmaceuticals made up 0.01% of Elo Mutual Pension Insurance's portfolio in Q2 2026, its #512 holding.
  • Elo Mutual Pension Insurance first reported a position in BioCryst Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • Elo Mutual Pension Insurance's BioCryst Pharmaceuticals position peaked at $968K in Q3 2025.
  • 318 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q2 2026.

Based on Elo Mutual Pension Insurance's 13F filing for Q2 2026, filed 13 Aug 2026.